Pharma Mar Launches Employee Share Plan From Treasury Stock

Pharma Mar SA ( (ES:PHM) ) has provided an announcement.

Pharma Mar’s Executive Commission has activated a previously approved share delivery plan from treasury stock, distributing up to 12,042 shares, or 0.067% of share capital, to employees and executives of Grupo Pharma Mar. The scheme is designed to increase staff participation in the company’s equity and support retention, explicitly excluding members of the Board of Directors as beneficiaries.

Under the plan, shares are granted free of charge with a three-year lock-up “Loyalty Period,” during which they cannot be sold, although half of each grant is unblocked after 18 months while retaining full political and economic rights. The awards, valued in total at about €982,000 using a reference price of €81.5724 per share to calculate allocations, include clawback-style conditions tied to employment status, aligning employee incentives with long-term performance while limiting dilution for existing shareholders.

The most recent analyst rating on (ES:PHM) stock is a Buy with a EUR89.00 price target. To see the full list of analyst forecasts on Pharma Mar SA stock, see the ES:PHM Stock Forecast page.

More about Pharma Mar SA

Pharma Mar, S.A. is a Spanish biopharmaceutical company focused on oncology, developing and commercializing innovative cancer therapies derived from marine resources. The group targets global specialty pharma markets, leveraging its R&D pipeline and marketed drugs to strengthen its position in high-value oncology niches.

Average Trading Volume: 40,789

Technical Sentiment Signal: Strong Buy

Current Market Cap: €1.55B

See more insights into PHM stock on TipRanks’ Stock Analysis page.